Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists
DXCM

DXCM - DexCom Inc Stock Price, Fair Value and News

$75.36+0.11 (+0.15%)
Market Closed as of 12 Jun 2026, 04:00 pm ET

62/100

DXCM

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

62/100

DXCM

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

DXCM Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

DXCM Price Action

Last 7 days

3.4%

Last 30 days

28.7%

Last 90 days

17.3%

Trailing 12 Months

-9.0%

DXCM RSI Chart

DXCM Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

DXCM Valuation

Market Cap

29.1B

Price/Earnings (Trailing)

31.26

Price/Sales (Trailing)

6.04

EV/EBITDA

18.97

Price/Free Cashflow

20.35

DXCM Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

DXCM Fundamentals

DXCM Revenue

Revenue (TTM)

4.8B

Rev. Growth (Yr)

15.05%

Rev. Growth (Qtr)

-5.37%

DXCM Earnings

Earnings (TTM)

930.4M

Earnings Growth (Yr)

89.28%

Earnings Growth (Qtr)

-25.36%

DXCM Profitability

Operating Margin

95.95%

EBT Margin

24.98%

Return on Equity

31.47%

Return on Assets

14.03%

Free Cashflow Yield

4.92%

DXCM Investor Care

Buy Backs (1Y)

1.33%

Diluted EPS (TTM)

2.33

DXCM Alerts

  • 3 major insider sales recently.
  • Big jump in Earnings (Y/Y)

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20264.8B000
20254.1B4.3B4.5B4.7B
20243.8B3.9B4.0B4.0B
20233.0B3.2B3.4B3.6B
20222.6B2.7B2.8B2.9B
20212.0B2.2B2.3B2.4B
20201.6B1.7B1.8B1.9B
20191.1B1.2B1.4B1.5B
2018760.6M832.5M914.6M1.0B
2017599.4M632.7M668.7M718.5M
2016445.4M489.8M534.2M573.3M
2015285.1M319.2M354.4M402.0M
2014177.1M200.1M226.2M259.0M
2013109.5M121.8M141.6M160.0M
201282.2M84.3M89.1M100.0M
2011062.9M69.5M76.3M
Get all data in R, Python etc through our Historical Stock Data APIs

About DexCom Inc

DXCM
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
 CEO
 WEBSITEdexcom.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES7500

DexCom Inc Frequently Asked Questions

DXCM is the stock ticker symbol of DexCom Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Jun 12 2026, market cap of DexCom Inc is 29.08 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Fri Jun 12 2026, DXCM's PE ratio (Price to Earnings) is 31.26 and Price to Sales (PS) ratio is 6.04. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. DXCM PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, DexCom Inc has provided 0.152 (multiply by 100 for percentage) rate of return.